Undervalued biotech pharma is getting attention. Short term 10% return!! Below is the facts about DSCO I just copied from DSCO yahoo message board: Facts: 1. one approved device 2. one approved drug 3. $40 million in cash 4. no debts 5. no preferred stocks 6. no warrnts 8. exclusive rights 9. excellent pipeline 10. Newly partnership 11. MAA approval soon 12. New device new drug launch soon 13. Mkt Cap 128 million ??? At 3 times sales, this is already $400 million firm, and that is $10 PPS. DSCO === Hidden Jem.
【在 g****e 的大作中提到】 : Undervalued biotech pharma is getting attention. Short term 10% return!! : Below is the facts about DSCO I just copied from DSCO yahoo message board: : Facts: : 1. one approved device : 2. one approved drug : 3. $40 million in cash : 4. no debts : 5. no preferred stocks : 6. no warrnts : 8. exclusive rights
s*h
5 楼
没有胸, pass
g*e
6 楼
We should respects these startup companies who have gotten FDA approvals. Nowdays it is very difficult to get OK from FDA, 95% of companies failed after burned minions $$$. Let's wait and see, time will tell.